Overactive bladder Trials in Las Vegas, United States
Conditions / Overactive bladder / Las Vegas, United States
Overactive bladder is a medical condition with active clinical research programs worldwide.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01972841 | This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder | COMPLETED | PHASE3 |
| NCT00350636 | A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo | COMPLETED | PHASE3 |
| NCT03583372 | An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). | COMPLETED | PHASE3 |
| NCT03902080 | Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) | COMPLETED | PHASE3 |
| NCT00685113 | A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder | COMPLETED | PHASE3 |
| NCT03492281 | A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) | COMPLETED | PHASE3 |
| NCT00536484 | Fesoterodine Flexible Dose Study | COMPLETED | PHASE3 |
| NCT00928070 | A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder | COMPLETED | PHASE4 |
| NCT00611026 | Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. | COMPLETED | PHASE3 |
| NCT01302067 | A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine | COMPLETED | PHASE4 |